FDA-Inspected Site

CASAD Company Inc

2 FDA inspections are on record for CASAD Company Inc in Coldwater, United States.

483· Form 483 issued

Coldwater, United States · Last updated July 11, 2026

Overview

  • 2 FDA inspections are on record.
  • 2 inspections produced a Form 483.
  • The most recent recorded inspection date is 2025-10-08.

At a glance

Inspections

2

Form 483s

2

EIRs

0

Last outcome

Form 483

Inspection history

FDA inspections on record, most recent first.

InspectionCategoryOutcomeForm 483
7 Oct 2025 – 8 Oct 2025Human Drugs483View 483 →
16 Aug 2021 – 18 Aug 2021Human Drugs483View 483 →

Observations on record

Form 483 observations cited at this site, most recent first.

8 Oct 2025
21 CFR 211.188

Prepared for each batch, include complete information

Cited by Anna M Spiros

8 Oct 2025
21 CFR 211.22(d)

Procedures not in writing, fully followed

Cited by Anna M Spiros

18 Aug 2021
21 CFR 211.122(a)

Written procedures not followed

Cited by Charles L Zhou, Lisa R Hilliard

18 Aug 2021
21 CFR 211.180(e)

Records reviewed annually

Cited by Charles L Zhou, Lisa R Hilliard

18 Aug 2021
21 CFR 211.22(d)

Procedures not in writing, fully followed

Cited by Charles L Zhou, Lisa R Hilliard

Investigators

FDA investigators tied to this site in the record.

Recurring citations

CFR citation patterns observed across this site's inspections.

CitationWhat it coversCited
21 CFR 211.22(d)Cited across public-safe Form 483 observations2x
21 CFR 211.122(a)Cited across public-safe Form 483 observations1x
21 CFR 211.180(e)Cited across public-safe Form 483 observations1x
21 CFR 211.188Cited across public-safe Form 483 observations1x
21 CFR 211.25(a)Cited across public-safe Form 483 observations1x
21 CFR 211.84(a)Cited across public-safe Form 483 observations1x

Full site report

Get the verbatim findings behind CASAD Company Inc's 2 Form 483s

Source PDFs and recurring CFR citations, so your team knows what this site gets cited for.

  • The site's full inspection history, with every Form 483 and its outcome
  • Warning letters and recalls tied to the company behind it
  • Whether recurring CFR citations get closed out or repeat